Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Underdiagnosis of Hereditary Breast and Ovarian Cancer in Medicare Patients: Genetic Testing Criteria Miss the Mark.

Yang S, Axilbund JE, O'Leary E, Michalski ST, Evans R, Lincoln SE, Esplin ED, Nussbaum RL.

Ann Surg Oncol. 2018 Oct;25(10):2925-2931. doi: 10.1245/s10434-018-6621-4. Epub 2018 Jul 11.

PMID:
29998407
2.

Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.

Solomon I, Harrington E, Hooker G, Erby L, Axilbund J, Hampel H, Semotiuk K, Blanco A, Klein WMP, Giardiello F, Leonard L.

J Genet Couns. 2017 Aug;26(4):866-877. doi: 10.1007/s10897-017-0066-y. Epub 2017 Jan 26.

PMID:
28127677
3.

Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board.

Dalton WB, Forde PM, Kang H, Connolly RM, Stearns V, Gocke CD, Eshleman JR, Axilbund J, Petry D, Geoghegan C, Wolff AC, Loeb DM, Pratilas CA, Meyer CF, Christenson ES, Slater SA, Ensminger J, Parsons HA, Park BH, Lauring J.

JCO Precis Oncol. 2017;2017. doi: 10.1200/PO.16.00046. Epub 2017 May 31.

4.

A Polycythemia Vera JAK2 Mutation Masquerading as a Duodenal Cancer Mutation.

Lee J, Axilbund J, Dalton WB, Laheru D, Watkins S, Chu D, Cravero K, Button B, Kyker-Snowman K, Waters I, Gocke CD, Lauring J, Park BH.

J Natl Compr Canc Netw. 2016 Dec;14(12):1495-1498.

PMID:
27956534
5.

Reply to M.J. Hall et al and K.N. Maxwell et al.

Axilbund JE.

J Clin Oncol. 2016 Dec;34(34):4187. Epub 2016 Oct 31. No abstract available.

PMID:
27551122
6.

Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer.

Parsons HA, Beaver JA, Cimino-Mathews A, Ali SM, Axilbund J, Chu D, Connolly RM, Cochran RL, Croessmann S, Clark TA, Gocke CD, Jeter SC, Kennedy MR, Lauring J, Lee J, Lipson D, Miller VA, Otto GA, Rosner GL, Ross JS, Slater S, Stephens PJ, VanDenBerg DA, Wolff AC, Young LE, Zabransky DJ, Zhang Z, Zorzi J, Stearns V, Park BH.

Clin Cancer Res. 2017 Jan 15;23(2):379-386. doi: 10.1158/1078-0432.CCR-16-1543. Epub 2016 Aug 3.

7.

Panel Testing Is Not a Panacea.

Axilbund JE.

J Clin Oncol. 2016 May 1;34(13):1433-5. doi: 10.1200/JCO.2015.65.5522. Epub 2016 Mar 14. No abstract available.

PMID:
26976416
8.

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.

Daly MB, Pilarski R, Axilbund JE, Berry M, Buys SS, Crawford B, Farmer M, Friedman S, Garber JE, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Rana H, Reiser G, Robson ME, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wick MJ, Wiesner GL, Dwyer M, Kumar R, Darlow S.

J Natl Compr Canc Netw. 2016 Feb;14(2):153-62.

PMID:
26850485
9.

Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer.

Roberts NJ, Norris AL, Petersen GM, Bondy ML, Brand R, Gallinger S, Kurtz RC, Olson SH, Rustgi AK, Schwartz AG, Stoffel E, Syngal S, Zogopoulos G, Ali SZ, Axilbund J, Chaffee KG, Chen YC, Cote ML, Childs EJ, Douville C, Goes FS, Herman JM, Iacobuzio-Donahue C, Kramer M, Makohon-Moore A, McCombie RW, McMahon KW, Niknafs N, Parla J, Pirooznia M, Potash JB, Rhim AD, Smith AL, Wang Y, Wolfgang CL, Wood LD, Zandi PP, Goggins M, Karchin R, Eshleman JR, Papadopoulos N, Kinzler KW, Vogelstein B, Hruban RH, Klein AP.

Cancer Discov. 2016 Feb;6(2):166-75. doi: 10.1158/2159-8290.CD-15-0402. Epub 2015 Dec 9.

10.

Clinical Characteristics of Multiple Colorectal Adenoma Patients Without Germline APC or MYH Mutations.

Tieu AH, Edelstein D, Axilbund J, Romans KE, Brosens LA, Wiley E, Hylind L, Giardiello FM.

J Clin Gastroenterol. 2016 Aug;50(7):584-8. doi: 10.1097/MCG.0000000000000416.

11.

Weight change in breast cancer survivors compared to cancer-free women: a prospective study in women at familial risk of breast cancer.

Gross AL, May BJ, Axilbund JE, Armstrong DK, Roden RB, Visvanathan K.

Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1262-9. doi: 10.1158/1055-9965.EPI-15-0212. Epub 2015 Jul 15.

12.

Risk of Colorectal and Other Cancers in Patients With Serrated Polyposis.

Edelstein DL, Cruz-Correa M, Soto-Salgado M, Axilbund JE, Hylind LM, Romans K, Blair C, Wiley E, Tersmette AC, Offerhaus JA, Giardiello FM.

Clin Gastroenterol Hepatol. 2015 Sep;13(9):1697-9. doi: 10.1016/j.cgh.2015.02.003. Epub 2015 Feb 11.

13.

Genetic/familial high-risk assessment: breast and ovarian, version 1.2014.

Daly MB, Pilarski R, Axilbund JE, Buys SS, Crawford B, Friedman S, Garber JE, Horton C, Kaklamani V, Klein C, Kohlmann W, Kurian A, Litton J, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Pasche B, Reiser G, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wiesner GL, Dwyer MA, Kumar R; National comprehensive cancer network.

J Natl Compr Canc Netw. 2014 Sep;12(9):1326-38.

PMID:
25190698
14.

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer.

Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, Church JM, Dominitz JA, Johnson DA, Kaltenbach T, Levin TR, Lieberman DA, Robertson DJ, Syngal S, Rex DK.

Am J Gastroenterol. 2014 Aug;109(8):1159-79. doi: 10.1038/ajg.2014.186. Epub 2014 Jul 22.

PMID:
25070057
15.

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer.

Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, Church JM, Dominitz JA, Johnson DA, Kaltenbach T, Levin TR, Lieberman DA, Robertson DJ, Syngal S, Rex DK; US Multi-Society Task Force on Colorectal Cancer.

Gastroenterology. 2014 Aug;147(2):502-26. doi: 10.1053/j.gastro.2014.04.001. Review.

PMID:
25043945
16.

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer.

Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, Church JM, Dominitz JA, Johnson DA, Kaltenbach T, Levin TR, Lieberman DA, Robertson DJ, Syngal S, Rex DK; American Society for Gastrointestinal Endoscopy.

Gastrointest Endosc. 2014 Aug;80(2):197-220. doi: 10.1016/j.gie.2014.06.006. Review. No abstract available.

PMID:
25034835
17.

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer.

Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, Church JM, Dominitz JA, Johnson DA, Kaltenbach T, Levin TR, Lieberman DA, Robertson DJ, Syngal S, Rex DK.

Dis Colon Rectum. 2014 Aug;57(8):1025-48. doi: 10.1097/DCR.000000000000000.

PMID:
25003300
18.

The increasing incidence of young-onset colorectal cancer: a call to action.

Ahnen DJ, Wade SW, Jones WF, Sifri R, Mendoza Silveiras J, Greenamyer J, Guiffre S, Axilbund J, Spiegel A, You YN.

Mayo Clin Proc. 2014 Feb;89(2):216-24. doi: 10.1016/j.mayocp.2013.09.006. Epub 2014 Jan 4.

PMID:
24393412
19.

Genetic testing by cancer site: pancreas.

Axilbund JE, Wiley EA.

Cancer J. 2012 Jul-Aug;18(4):350-4. doi: 10.1097/PPO.0b013e3182624694. Review.

PMID:
22846737
20.

ATM mutations in patients with hereditary pancreatic cancer.

Roberts NJ, Jiao Y, Yu J, Kopelovich L, Petersen GM, Bondy ML, Gallinger S, Schwartz AG, Syngal S, Cote ML, Axilbund J, Schulick R, Ali SZ, Eshleman JR, Velculescu VE, Goggins M, Vogelstein B, Papadopoulos N, Hruban RH, Kinzler KW, Klein AP.

Cancer Discov. 2012 Jan;2(1):41-6. doi: 10.1158/2159-8290.CD-11-0194. Epub 2011 Dec 29.

21.

Serrated polyposis: rapid and relentless development of colorectal neoplasia.

Edelstein DL, Axilbund JE, Hylind LM, Romans K, Griffin CA, Cruz-Correa M, Giardiello FM.

Gut. 2013 Mar;62(3):404-8. doi: 10.1136/gutjnl-2011-300514. Epub 2012 Apr 5.

22.

Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.

Canto MI, Hruban RH, Fishman EK, Kamel IR, Schulick R, Zhang Z, Topazian M, Takahashi N, Fletcher J, Petersen G, Klein AP, Axilbund J, Griffin C, Syngal S, Saltzman JR, Mortele KJ, Lee J, Tamm E, Vikram R, Bhosale P, Margolis D, Farrell J, Goggins M; American Cancer of the Pancreas Screening (CAPS) Consortium.

Gastroenterology. 2012 Apr;142(4):796-804; quiz e14-5. doi: 10.1053/j.gastro.2012.01.005. Epub 2012 Jan 12.

23.

A new phenotypic manifestation of familial adenomatous polyposis.

Edelstein DL, Giardiello FM, Basiri A, Hylind LM, Romans K, Axilbund JE, Cruz-Correa M, Ramella-Roman JC.

Fam Cancer. 2011 Jun;10(2):309-13. doi: 10.1007/s10689-011-9432-3.

24.

Rapid development of colorectal neoplasia in patients with Lynch syndrome.

Edelstein DL, Axilbund J, Baxter M, Hylind LM, Romans K, Griffin CA, Cruz-Correa M, Giardiello FM.

Clin Gastroenterol Hepatol. 2011 Apr;9(4):340-3. doi: 10.1016/j.cgh.2010.10.033. Epub 2010 Nov 9.

25.

Genetic/familial high-risk assessment: breast and ovarian.

Daly MB, Axilbund JE, Buys S, Crawford B, Farrell CD, Friedman S, Garber JE, Goorha S, Gruber SB, Hampel H, Kaklamani V, Kohlmann W, Kurian A, Litton J, Marcom PK, Nussbaum R, Offit K, Pal T, Pasche B, Pilarski R, Reiser G, Shannon KM, Smith JR, Swisher E, Weitzel JN; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2010 May;8(5):562-94. No abstract available.

PMID:
20495085
26.

Absence of germline BRCA1 mutations in familial pancreatic cancer patients.

Axilbund JE, Argani P, Kamiyama M, Palmisano E, Raben M, Borges M, Brune KA, Goggins M, Hruban RH, Klein AP.

Cancer Biol Ther. 2009 Jan;8(2):131-5. Epub 2009 Feb 4.

27.

Familial pancreatic cancer: from genes to improved patient care.

Hruban RH, Klein AP, Eshleman JR, Axilbund JE, Goggins M.

Expert Rev Gastroenterol Hepatol. 2007 Oct;1(1):81-8. doi: 10.1586/17474124.1.1.81. Review.

PMID:
19072437
28.

Patient preferences regarding recontact by cancer genetics clinicians.

Griffin CA, Axilbund JE, Codori AM, Deise G, May B, Pendergrass C, Tillery M, Trimbath JD, Giardiello FM.

Fam Cancer. 2007;6(3):265-73. Epub 2007 Feb 17.

PMID:
17308889
29.

Risk of colorectal cancer in juvenile polyposis.

Brosens LA, van Hattem A, Hylind LM, Iacobuzio-Donahue C, Romans KE, Axilbund J, Cruz-Correa M, Tersmette AC, Offerhaus GJ, Giardiello FM.

Gut. 2007 Jul;56(7):965-7. Epub 2007 Feb 15.

30.

Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.

Canto MI, Goggins M, Hruban RH, Petersen GM, Giardiello FM, Yeo C, Fishman EK, Brune K, Axilbund J, Griffin C, Ali S, Richman J, Jagannath S, Kantsevoy SV, Kalloo AN.

Clin Gastroenterol Hepatol. 2006 Jun;4(6):766-81; quiz 665. Epub 2006 May 6.

PMID:
16682259
31.

Genetic/familial high-risk assessment: breast and ovarian.

Daly MB, Axilbund JE, Bryant E, Buys S, Eng C, Friedman S, Esserman LJ, Farrell CD, Ford JM, Garber JE, Jeter JM, Kohlmann W, Lynch PM, Marcom PK, Nabell LM, Offit K, Osarogiagbon RU, Pasche B, Reiser G, Sutphen R, Weitzel JN; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2006 Feb;4(2):156-76. No abstract available.

PMID:
16451772
32.

Assessment of the use and feasibility of video to supplement the genetic counseling process: a cancer genetic counseling perspective.

Axilbund JE, Hamby LA, Thompson DB, Olsen SJ, Griffin CA.

J Genet Couns. 2005 Jun;14(3):235-43.

PMID:
15959654
33.

Patient perspective on the value of genetic counselling for familial pancreas cancer.

Axilbund JE, Brune KA, Canto MI, Brehon BC, Wroblewski LD, Griffin CA.

Hered Cancer Clin Pract. 2005 Aug 15;3(3):115-22. doi: 10.1186/1897-4287-3-3-115.

34.

Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.

Canto MI, Goggins M, Yeo CJ, Griffin C, Axilbund JE, Brune K, Ali SZ, Jagannath S, Petersen GM, Fishman EK, Piantadosi S, Giardiello FM, Hruban RH.

Clin Gastroenterol Hepatol. 2004 Jul;2(7):606-21.

PMID:
15224285

Supplemental Content

Loading ...
Support Center